[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![GSK plc Graphic](https://lunarcrush.com/gi/w:26/t:gsk-plc.png) GSK plc (GSK)

GSK shares are slipping after FDA flags eye safety risks in blood cancer drug review. GSK begins shipping influenza vaccine doses for the 2025-26 flu season.

### About GSK plc
GSK plc (GSK) is a pharmaceutical company.  
GSK plc uses the ticker $GSK for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/gsk-plc/insights)
- GSK plc (GSK) mentions is at XXX which is XXX% higher than it's daily average.
- GSK plc (GSK) engagements is at XXXXXX which is XXX% higher than it's daily average.
- GSK plc (GSK) trading volume is up XXXXXX% from the previous week.
- GSK plc (GSK) social dominance is up XXXXXX% from the previous week.
- GSK plc (GSK) engagements is up XXX% from the previous week.
- GSK plc (GSK) posts created is up XXXXXX% from the previous month.

### Price: $XXXXX [#](/topic/gsk-plc/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:close.svg)  
[Price 24-Hour Chart Data](/topic/gsk-plc/time-series/close.tsv)  
The price is trending upward, likely driven by recent positive news about acquisitions and drug approvals, with the latest news indicating GSK begins shipping influenza vaccine doses for the 2025-26 flu season.  

| 24-Hour | 7-Day  | 30-Day |
| ------- | -----  | ------ |
| -XXXX%  | -XXXX% | -XXXX% |

**1-Year High**: $XXXXX on 2024-09-04  
**1-Year Low**: $XXXXX on 2025-01-14  
  
  
### AltRank: XXXXX [#](/topic/gsk-plc/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:alt_rank.svg)  
[AltRank 24-Hour Chart Data](/topic/gsk-plc/time-series/alt_rank.tsv)  
GSK plc (GSK) is currently AltRank #1,213 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXXXX +760  
**1 Month**: XXXXX +557  
**6 Months**: XXXXX +990  
**1 Year**: XXXXX +903  
**1-Year High**: XXXXX on 2024-11-11  
**1-Year Low**: X on 2025-02-09  
  
  
### Galaxy Score: XXXXX [#](/topic/gsk-plc/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:galaxy_score.svg)  
[Galaxy Score 24-Hour Chart Data](/topic/gsk-plc/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX -XX  
**1 Month**: XX -X  
**6 Months**: XX +16  
**1 Year**: XX -XX  
**1-Year High**: XX on 2025-05-13  
**1-Year Low**: XX on 2025-07-03  
  
  
### Engagements: XXXXXX [#](/topic/gsk-plc/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/gsk-plc/time-series/interactions.tsv)  
**Current Value**: XXXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXXX +126%  
**1 Month**: XXXXXXX +8.50%  
**6 Months**: XXXXXXXXX -XX%  
**1 Year**: XXXXXXXXX -XX%  
**1-Year High**: XXXXXXX on 2024-12-05  
**1-Year Low**: XXX on 2025-04-20  

| Social Network | X      | News | YouTube | Reddit | TikTok |
| -------------- | -      | ---- | ------- | ------ | ------ |
| Engagements    | XXXXXX | X    | X       | X      | X      |
  

  
  
### Mentions: XXX [#](/topic/gsk-plc/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/gsk-plc/time-series/posts_active.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Week**: XXX -XX%  
**1 Month**: XXXXX +147%  
**6 Months**: XXXXX +6.20%  
**1 Year**: XXXXX +92%  
**1-Year High**: XXX on 2025-06-28  
**1-Year Low**: XX on 2024-09-29  

| Social Network | X   | News | YouTube | Reddit | TikTok |
| -------------- | -   | ---- | ------- | ------ | ------ |
| Mentions       | XXX | X    | X       | X      | X      |
  

  
  
### Creators: XXX [#](/topic/gsk-plc/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/gsk-plc/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning GSK plc (GSK) in the last XX hours which is up XXXX% from XXX in the previous XX hours
**Daily Average**: XX  
**1 Week**: XXX -XX%  
**1 Month**: XXX +241%  
**6 Months**: XXXXX +33%  
**1 Year**: XXXXX +143%  
**1-Year High**: XXX on 2025-06-28  
**1-Year Low**: XX on 2024-09-29  

The most influential creators that mention GSK plc in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@JacobPlieth](/creator/twitter/JacobPlieth)         | X    | XXXXXX    | XX    | XXXXXX      |
| [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) | X    | XXXXX     | XX    | XXXXXX      |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | X    | XXXXXX    | X     | XXXXXX      |
| [@Trade_The_News](/creator/twitter/Trade_The_News)   | X    | XXXXXX    | X     | XXXXX       |
| [@bio_clouseau](/creator/twitter/bio_clouseau)       | X    | XXXXXX    | X     | XXXXX       |
| [@CaroIHughes](/creator/twitter/CaroIHughes)         | X    | XXX       | X     | XXX         |
| [@RuthMiIIer](/creator/twitter/RuthMiIIer)           | X    | XXX       | X     | XXX         |
| [@ajit_x_singh](/creator/twitter/ajit_x_singh)       | X    | XXX       | X     | XXX         |
| [@SarahUJones](/creator/twitter/SarahUJones)         | X    | XXX       | X     | XXX         |
| [@Sharon_Colemann](/creator/twitter/Sharon_Colemann) | XX   | XXX       | X     | XXX         |

[View More](/list/creators/gsk-plc/100)
  
  
### Sentiment: XX% [#](/topic/gsk-plc/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/gsk-plc/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% -X%  
**6 Months**: XX% -XX%  
**1 Year**: XX% -XX%  
**1-Year High**: XXX% on 2024-07-18  
**1-Year Low**: XX% on 2025-01-26  

**Most Supportive Themes**
- **New Drug Approvals and Acquisition:** (55%) Positive data, new drug approvals, and the acquisition of a new drug are driving positive sentiment around GSK.
- **Positive outlook on new drugs:** (25%) Positive outlook on new drugs and the potential for these drugs to have a large impact on sales growth.
  
**Most Critical Themes**
- **Drug Price & GLP-1 Drug Concerns:** (0.5%)  Concerns about drug prices and risks associated with GLP-1 drugs are being discussed.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XXXXXX   | XX% | XXXXXX  | XX% | XXXXXX   | XX% |
| News    | X        | X%  | X       | X%  | X        | X%  |
| YouTube | X        | X%  | X       | X%  | X        | X%  |
| Reddit  | X        | X%  | X       | X%  | X        | X%  |
| TikTok  | X        | X%  | X       | X%  | X        | X%  |
|         |          |     |         |     |          |     |
| Total   | XXXXXX   | XX% | XXXXXX  | XX% | XXXXXX   | XX% |
  

  
  
### Social Dominance: XXXXX% [#](/topic/gsk-plc/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:social_dominance.svg)  
[Social Dominance 24-Hour Chart Data](/topic/gsk-plc/time-series/social_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXX% +0.022%  
**1 Month**: XXXXX% -XXXXX%  
**6 Months**: XXXXX% +0.0014%  
**1 Year**: XXXXX% -XXXXXX%  
**1-Year High**: XXXXX% on 2025-06-28  
**1-Year Low**: XXXXX% on 2025-07-09  
  
  
### Market Dominance: XXXXX% [#](/topic/gsk-plc/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:market_dominance.svg)  
[Market Dominance 24-Hour Chart Data](/topic/gsk-plc/time-series/market_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXX% on 2024-09-07  
**1-Year Low**: XXXXX% on 2025-07-17  
  
  
### Market Cap: $XXXXXXXXXXXXXX [#](/topic/gsk-plc/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:market_cap.svg)  
[Market Cap 24-Hour Chart Data](/topic/gsk-plc/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXXX -$6.70%  
**1 Month**: $XXXXXXXXXXXXXX -$6.70%  
**6 Months**: $XXXXXXXXXXXXXX +$10%  
**1 Year**: $XXXXXXXXXXXXXX -$7.60%  
**1-Year High**: $XXXXXXXXXXXXXX on 2024-09-04  
**1-Year Low**: $XXXXXXXXXXXXXX on 2025-01-14  

**Top assets mentioned**
In the posts about GSK plc in the last XX hours

[GSK plc (GSK)](/topic/$gsk)
[Hims & Hers Health, Inc. (HIMS)](/topic/$hims)
[Eli Lilly and Company (LLY)](/topic/$lly)
[Synthetify (SNY)](/topic/$sny)
[Novartis AG (NVS)](/topic/$nvs)
[Omnicom Group Inc. (OMC)](/topic/$omc)
[Molina Healthcare, Inc. (MOH)](/topic/$moh)
[Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn)
[Johnson & Johnson (JNJ)](/topic/$jnj)

**Top topics mentioned**
In the posts about GSK plc in the last XX hours

[manat](/topic/manat), [$hims](/topic/$hims), [$vani](/topic/$vani), [hims](/topic/hims), [$zldpf](/topic/$zldpf), [stocks healthcare](/topic/stocks-healthcare), [asml](/topic/asml), [$rhhby](/topic/$rhhby), [qqq](/topic/qqq), [spx](/topic/spx), [stocks](/topic/stocks), [$lly](/topic/$lly), [$sny](/topic/$sny), [investment](/topic/investment), [$nvs](/topic/$nvs), [$ive](/topic/$ive), [mstr](/topic/mstr), [$omc](/topic/$omc), [$moh](/topic/$moh), [$regn](/topic/$regn), [$vgsh](/topic/$vgsh), [$jnj](/topic/$jnj), [nke](/topic/nke), [coins ai](/topic/coins-ai), [$djt](/topic/$djt), [wm](/topic/wm), [vix](/topic/vix), [op](/topic/op), [$jd](/topic/$jd), [$brcc](/topic/$brcc), [coins healthcare](/topic/coins-healthcare), [spy](/topic/spy), [nvda](/topic/nvda), [$asnd](/topic/$asnd), [$repl](/topic/$repl), [$iei](/topic/$iei), [$gild](/topic/$gild), [$pfe](/topic/$pfe), [dd](/topic/dd), [bdx](/topic/bdx), [amzn](/topic/amzn), [acquisition](/topic/acquisition), [$etsy](/topic/$etsy), [$kalv](/topic/$kalv), [abbv](/topic/abbv), [jnj](/topic/jnj), [$azn](/topic/$azn), [pltr](/topic/pltr), [rio](/topic/rio), [vale](/topic/vale), [srm](/topic/srm), [$scha](/topic/$scha), [$vrtx](/topic/$vrtx), [drugs](/topic/drugs), [$mmm](/topic/$mmm), [$crm](/topic/$crm), [approved](/topic/approved), [teva](/topic/teva), [hum](/topic/hum), [bloomberg](/topic/bloomberg), [cfg](/topic/cfg), [$metc](/topic/$metc), [$vymi](/topic/$vymi), [elf](/topic/elf), [luv](/topic/luv), [$vrna](/topic/$vrna), [tak](/topic/tak), [$agen](/topic/$agen), [china](/topic/china), [japan](/topic/japan), [$se](/topic/$se), [$rblx](/topic/$rblx), [$btu](/topic/$btu), [$vtrs](/topic/$vtrs), [$el](/topic/$el), [$cogt](/topic/$cogt), [$legn](/topic/$legn), [ads](/topic/ads), [unitedhealth group](/topic/unitedhealth-group), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$ctos](/topic/$ctos), [$lixt](/topic/$lixt), [realdonaldtrump](/topic/realdonaldtrump), [potus](/topic/potus), [crcl](/topic/crcl), [$iwf](/topic/$iwf), [ita unibanco](/topic/ita-unibanco), [$tt](/topic/$tt), [$20s](/topic/$20s), [$cvac](/topic/$cvac), [signals](/topic/signals), [stockmarket](/topic/stockmarket), [told](/topic/told), [$deck](/topic/$deck), [$bti](/topic/$bti), [coins energy](/topic/coins-energy), [$4m](/topic/$4m), [$blk](/topic/$blk), [$bx](/topic/$bx), [$luv](/topic/$luv)

### Top Social Posts [#](/topic/gsk-plc/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$GSK 📣 FDAs ODAC votes against belantamab mafodotin combos in R/R multiple myeloma ❌ XX vote against BVd (with bortezomib) 👎👎👎👎👎 vs. 👍👍👍 ❌ XX vote against BPd (with pomalidomide) 👎👎👎👎👎👎👎 vs. 👍 ⚠ Reason: High ocular toxicity & poor tolerability despite PFS gains in DREAMM-7/8 FDA questioned dosage selection & real-world relevance of trial data Committee urged exploration of lower more tolerable doses 📉 A tough call: Strong efficacy but stronger toxicity concerns"  
[@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945960037979242732) 2025-07-17 21:33:21 UTC 25.5K followers, 3251 engagements


"@_SuccessPatrick @hugabiola @OzorNdiOzor @AnambraNewMedia Another angle na waooo abegi rest this matter naaa. Even with a clear meaning pure white colour and it is being coloured to suit a narrative. GSK Plc Procter and Gamble PZ Cussons Equinox etc benefited the almighty FG and yet left. Ndi indigenous make I hear word"  
[@Zimakonuche](/creator/x/Zimakonuche) on [X](/post/tweet/1945953352602284384) 2025-07-17 21:06:47 UTC XXX followers, XX engagements


"GSK's bid to revive Blenrep hits snag after negative FDA adcom $GSK"  
[@fwpharma](/creator/x/fwpharma) on [X](/post/tweet/1945943789727609081) 2025-07-17 20:28:48 UTC 55.1K followers, XXX engagements


"RECAP 7/17 CHATTER: $MO $BTI + FDA JUUL $STNG + BETAVILLE $GSK - FDA REJECTS BLOOD CANCER DRUG $TSLA - CHINA BATTERY MATERIAL TARIFF $LAC $ABAT $PLL $MP + $AMBC + LEGACY BIZ SALE HEARING $DXCM - RECALL $CMCSA + PEACOCK +$3 $SOC + COURT RULING $RDHL + EU PATENT LIVE BREAKIN"  
[@MarketNews_Feed](/creator/x/MarketNews_Feed) on [X](/post/tweet/1945936873043423644) 2025-07-17 20:01:18 UTC XXX followers, XXX engagements